Testing effectiveness (Phase 2)UnknownNCT05381662
What this trial is testing
CD19 Chimeric Antigen Receptors and CD19 Positive Feeder T Cells as a Leukemia Consolidation Treatment
Who this might be right for
Acute Lymphoblastic Leukemia in Remission
Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd 10